Incidence of hypersensitivity reactions

Annals of Thoracic Surgery

Volumn 65, Issue 6 SUPPL., 1998, Pages

  Dietrich, Wulf ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CIMETIDINE; CLEMASTINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; SERINE PROTEINASE INHIBITOR;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; CARDIOVASCULAR SURGERY; CHILD; CONFERENCE PAPER; CORONARY CARE UNIT; DRUG HYPERSENSITIVITY; DRUG REEXPOSURE; FEMALE; GERMANY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; AGED; APROTININ; CHILD; DRUG HYPERSENSITIVITY; FEMALE; HEMOSTATICS; HUMANS; INCIDENCE; MALE; SERINE PROTEINASE INHIBITORS;

EID: 0031803152     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00333-6     Document Type: Conference Paper

References (17)

1. Fritz H., Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung. 33:1983;479-494.
2. Böhrer H., Bach A., Fleiscner F., et al. Adverse haemodynamic effect of high-dose aprotinin in a paediatric cardiac surgical patient. Anaesthesia. 45:1995;853-854.
3. Ceriana P., Maurelli M., Locatelli A., et al. Anaphylactic reaction to aprotinin [Letter]. J Cardiothorac Vasc Anesth. 9:1995;477-484.
4. Dawachter P., Mouton O., Masson O., et al. Anaphylactic reaction to aprotinin during cardiac surgery [Letter]. Anaesthesia. 48:1993;1110-1111.
5. Diefenbach C., Abel M., Limpers B., et al. Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery. Anesth Analg. 80:1995;830-831.
6. Freeman J.G., Turner G.A., Venables C.W., et al. Serial use of aprotinin and incidence of allergic reactions. Curr Med Res Opin. 8:1983;559-561.
7. Schulze K., Graeter T., Schaps D., et al. Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement. Eur J Cardiothorac Surg. 7:1993;495-496.
8. Schuler T.M., Frosch P.J., Arza D., et al. Allergie vom Sofortlyp anaphylaktische Reaktion aul Aprotinin . München Med Wochenschr. 129:1987;816-817.
9. Yanagihara Y., Shida T. Immunological studies on patients who received aprotinin therapy. Jpn J Altergol. 34:1985;899-904.
10. Wuthrich B., Schmid P., Schmid E.R., et al. IgE-mediated anaphylactic reaction to aprotinin during anaesthesia [Letter]. Lancet. 340:1992;173-174.
11. Cosgrove D.M. III, Heric B., Lytle B.W., et al. Aprotinin therapy for reoperative myocardial revascularization a placebo-controlled study . Ann Thorac Surg. 54:1992;1031-1038.
12. Levy J.H., Pifarré R., Schaff H.V., et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation. 92:1995;2236-2244.
13. Dietrich W., Spath P., Ebell A., et al. Prevelance of anaphylactic reactions to aprotinin analysis of two hundred forty-eight reexposures to aprotinin in heart operations . J Thorac Cardiovasc Surg. 113:1997;194-201.
14. Weipert J., Meisner H., Jochum M., Dietrich W. Long-time follow-up of aprotinin-specific immunoglobulin G antibodies after cardiac operations. J Thorac Cardiovasc Surg. 114:1997;676-678.
15. Scheule A.M., Jurmann M.J., Wendel H.P., et al. Anaphylactic shock after aprotinin reexposure time course of aprotinin-specific antibodies . Ann Thorac Surg. 63:1997;242-244.
16. Dietrich W., Spannagl M., Jochum M. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology. 73:1990;1119-1126.
17. Levy J.H. Antibody formation after drug administration during cardiac surgery parameters for aprotinin use . J Heart Lung Transplant. 12:1993;S26-S33.